You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
希瑪醫療(03309.HK):2024年實現收益19.13億港元 擬派年度末期息每股2港仙
格隆匯 03-21 16:36

格隆匯3月21日丨希瑪醫療(03309.HK)發佈公告,截至2024年12月31日止年度,實現收益19.13億港元,同比減少0.6%;毛利爲5.28億港元,同比減少14.8%;公司權益持有人應佔虧損1.35億港元,上年同期公司權益持有人應佔溢利6199.8萬港元;公司權益持有人應佔經調整年內利潤爲5872.3萬港元,同比增加5.7%;EBITDA爲1.46億港元,同比減少57.4%;基本每股虧損10.96港仙,建議派付截至2024年12月31日止年度末期股息每股2.0港仙。

公告表示,由於整體業務營運質素提升及加強成本控制,撇除減值虧損及銷售醫療耗材分部(由於香港放寬COVID-19檢測的要求,於2023年下半年終止該分部的業務)的利潤的影響,公司權益持有人應佔利潤(“公司權益持有人應佔年內經調整利潤”)爲5870萬港元(2023年5560萬港元)。核心醫療服務收入由2023年的19.045億港元增加0.5%至19.132億港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account